neuro-specialty diseases
Lundbeck Offloads Assets to Three Partners as It Exits 27 Markets, Leaving 602 Jobless
Lundbeck; market exit; asset offloading; partnerships; job cuts; Swixx Group; Zuellig Pharma; NewBridge Pharmaceuticals; restructuring; neuro-rare diseases; neuro-specialty diseases